mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.09 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.09 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.09 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.09 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.09 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.1 |